Fifty years ago today, President John F. Kennedy signed a law that became a major milestone on the l...
In July, lurasidone—a dopamine receptor 2 (D2) blocker originally approved to treat schizophrenia—wa...
It has taken a century, but researchers are finally close to altering the outcomes of the most sever...
State laws requiring parity treatment for substance use disorder (SUD) that were enacted prior to th...
The Food and Drug Administration (FDA) yesterday approved Zohydro ER (hydrocodone bitartrate extende...
On Friday, the Food and Drug Administration (FDA) approved Vizamyl (flutemetamol) for use with posit...
